A randomized trial of deep-brain stimulation for Parkinson's disease

New England Journal of Medicine

Volumn 355, Issue 9, 2006, Pages 896-908

  Deuschl, Günther ^a   Schade Brittinger, Carmen ^b   Krack, Paul ^a   Volkmann, Jens ^a   Schäfer, Helmut ^b   Bötzel, Kai ^c   Daniels, Christine ^a   Deutschländer, Angela ^c   Dillmann, Ulrich ^d   Eisner, Wilhelm ^j   Gruber, Doreen ^e   Hamel, Wolfgang ^a   Herzog, Jan ^a   Hilker, Rüdiger ^f   Klebe, Stephan ^a   Kloß, Manja ^g   Koy, Jan ^h   Krause, Martin ^g   Kupsch, Andreas ^e   Lorenz, Delia ^a   Lorenzl, Stefan ^c   Mehdorn, H Maximilian ^a   Moringlane, Jean Richard ^d   Oertel, Wolfgang ^b   Pinsker, Marcus O ^a   Reichmann, Heinz ^h   Reuß, Alexander ^b   Schneider, Gerd Helge ^e   Schnitzler, Alfons ⁱ   Steude, Ulrich ^c   Sturm, Volker ^f   Timmermann, Lars ⁱ   Tronnier, Volker ^g   Trottenberg, Thomas ^e   Wojtecki, Lars ⁱ   Wolf, Elisabeth ^j   Poewe, Werner ^j   Voges, Jürgen ^f   more..

^a UNIVERSITY OF KIEL   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d Homburg University   (Germany)

^e HUMBOLDT UNIVERSITY   (Germany)

^f UNIVERSITY OF COLOGNE   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

ⁱ HEINRICH HEINE UNIVERSITY   (Germany)

^j INNSBRUCK MEDICAL UNIVERSITY   (Austria)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT OUTCOME; COMPARATIVE STUDY; DAILY LIFE ACTIVITY; DYSKINESIA; HOSPITALIZATION; MIDDLE AGED; MULTICENTER STUDY;

ANTIPARKINSON AGENT;

ACTIVITIES OF DAILY LIVING; AGED; ANTIPARKINSON AGENTS; DEEP BRAIN STIMULATION; DYSKINESIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33748139412     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa060281     Document Type: Article

References (36)

1. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-12.
2. Martinez-Martin P. An introduction to the concept of "quality of life in Parkinson's disease." J Neurol 1998;245:Suppl 1:S2-S6.
3. Goetz CG, Poewe W, Rascol O, Sampaio C. Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord 2005;20:523-39.
4. Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N Engl J Med 2000;342:1484-91.
5. The Deep-Brain Stimulation for Parkinson's Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-63.
6. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998;339:1105-11.
7. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-34.
8. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
9. Oertel W, Deuschl G, Eggert K, et al. Parkinson-Syndrome. In: Diener HC, ed. Leitlinien für Diagnostik und Therapie in der Neurologie: Stuttgart: Thieme-Verlag, 2003:38-57.
10. Berger K, Broll S, Winkelmann J, et al. Untersuchung zur Reliabilität der deutschen Version des PDQ-39: Ein krankheitsspezifischer Fragebogen zur Erfassung der Lebensqualität von Parkinson-Patienten. Akt Neurol 1999;26:180-4.
11. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995;4:241-8.
12. Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, eds. Recent developments in Parkinson's disease. Florham Park, N.J: MacMillan Health Care Information, 1987:153-63.
13. Marconi R, Lefebvre-Caparros D, Bonnet AM, Vidailhet M, Dubois B, Agid Y. Levodopa-induced dyskinesias in Parkinson's disease: phenomenology and pathophysiology. Mov Disord 1994;9:2-12.
14. Matthis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karatsu TB, eds. Geriatric psychiatry: a handbook for psychiatrists and primary care physicians. New York: Grune & Stratton, 1976:77-121.
15. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9.
16. Flemenbaum A, Zimmermann RL. Inter- and intra-rater reliability of the Brief Psychiatric Rating Scale. Psychol Rep 1973;32:783-92.
17. Bullinger M, Kirchberger I. SF-36, Fragebogen zum Gesundheitszustand: Handanweisung. Göttingen, Germany: Hogrefe, 1998.
18. Martinez-Martin P, Valldeoriola F, Molinuevo JL, Nobbe FA, Rumia J, Tolosa E. Pallidotomy and quality of life in patients with Parkinson's disease: an early study. Mov Disord 2000;15:65-70.
19. Fleming TR, Harrington DP, O'Brien PC. Designs for group sequential tests. Control Clin Trials 1984;5:348-61.
20. Hoehn MM, Yahr MD. Parksonism: onset, progression and mortality. Neurology 1967;17:427-42.
21. Martinez-Martin P, Valldeoriola F, Tolosa E, et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease. Mov Disord 2002;17:372-7.
22. Lezcano E, Gomez-Esteban JC, Zarranz JJ, et al. Improvement in quality of life in patients with advanced Parkinson's disease following bilateral deep-brain stimulation in subthalamic nucleus. Eur J Neurol 2004;11:451-4.
23. Weaver F, Follett K, Hur K, Ippolito D, Stern M. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. J Neurosurg 2005;103:956-67.
24. Schupbach WM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005;76:1640-4.
25. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005;128:2240-9.
26. Saint-Cyr JA, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000;123:2091-108.
27. Ardouin C, Pillon B, Peiffer E, et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999;46:217-23.
28. Berney A, Vingerhoets F, Perrin A, et al. Effect on mood of subthalamic DBS for Parkinson's disease: a consecutive series of 24 patients. Neurology 2002;59:1427-9.
29. Houeto JL, Mesnage V, Mallet L, et al. Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry 2002;72:701-7.
30. Global Parkinson's Disease Survey Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov Disord 2002;17:60-7.
31. Schrag A, Jahanshahi M, Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov Disord 2000;15:1112-8.
32. Biglan KM, Schwid S, Eberly S, et al. Rasagiline improves quality of life in patients with early Parkinson's disease. Mov Disord 2006;21:616-23.
33. Poewe WH, Deuschl G, Gordin A, Kultalahti ER, Leinonen M. Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal levodopa response: a 6-month randomized placebo-controlled double-blind study in Germany and Austria (Celomen study). Acta Neurol Scand 2002;105:245-55.
34. Reichmann H, Boas J, Macmahon D, Myllyla V, Hakala A, Reinikainen K. Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations. Acta Neurol Scand 2005;111:21-8.
35. Peto V, Jenkinson C, Fitzpatrick R. Determining minimally important differences for the PDQ-39 Parkinson's disease questionnaire. Age Ageing 2001;30:299-302.
36. Kim SY, Frank S, Holloway R, Zimmerman C, Wilson R, Kieburtz K. Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers. Arch Neurol 2005;62:1357-60.